Compare · head to head
Harvard Bioscience vs MindWalk Holdings
MindWalk Holdings ranks higher overall — 360 rank 59 vs 21.
Harvard Bioscience leads on Value (63 vs 46) and Quality (55 vs 44). MindWalk Holdings leads on Growth (56 vs 42), Safety (55 vs 19) and Sentiment (57 vs 38).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Life Sciences Tools & Services | Life Sciences Tools & Services |
| Size | Small | Small |
| ISIN | US4169061052 | CA6026871054 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 21 | 59 |
| Value | 63 | 46 |
| Quality | 55 | 44 |
| Growth | 42 | 56 |
| Safety | 19 | 55 |
| Sentiment | 38 | 57 |
| Quality details | ||
| Profitability | 55 | 31 |
| Cash Truth | 56 | 57 |
Harvard Bioscience vs Alpha TeknovaHarvard Bioscience vs BrukerHarvard Bioscience vs MaxCyteHarvard Bioscience vs IlluminaAdd a third stock →
Full analyses: Harvard Bioscience · MindWalk Holdings
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100